Others Flashcards

1
Q

Most common feature of MEN1 (occurs in 90%)

A

Primary hyperparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MEN1

A

Pancreatic tumors
Parathyroid
Pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medical treatment MEN1 Dillinger Ellison syndrome goal and drug of choice

A

Basal acid output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatment of disseminated gastrinomas

A
Chemo
Streptomycin
5- fluorouracil
Hormone therapy 
Ocreotide 
Lanreotide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MC pancreatic tumors in MEN 1 (>50%)

A

Gastrinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Characteristic clinical manifestations of glucagon a

A

Skin rash (necrolytic migratory erythema)
Weight loss
Anemia
Stomatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Medical treatment of insulinoma

A

Frequent carbohydrate meals
Diazoxide
Ocreotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Reported in few patients with MEN1
(+) watery diarrhea
Hypokalemia
Achlorydia

A

VIPomas (vasoactive intestinal peptide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aka

VERNER MORRISON SYNDROME

A

VIPomas

WDHA (watery diarrhea, hypokalemia and achlorydia) syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dx of VIPoma

A

Stool volume >0.5-1L / day during a fast

Markedly increased plasma VIP concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The most common enterobacter iv NET associated with MEN1

A

Nonfunctioning pancreatic NET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Criteria metabolic syndrome

A

Central obesity waist circumference >102 M, >88 cm

Hypertriglyceridemia >=150

Low HDL =130 or >=85 diastolic

FPG >= 100 mg/dl

Hypertension 130/80

3 or more!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most accepted and unifying hypothesis to describe the pathophysiology of metabolic syndrome

A

Insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Onset of insulin resistance in metabolic syndrome is heralded by

A

Post prandial hyperinsulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Excellent marker of the insulin resistant condition

A

Hypertriglyceridemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is there an assoc of insulin resistance and hypertension when insulin is a vasodilator?

A

In insulin resistance, vasodilator Y effect of insulin is lost, but renal effect on sodium reabsorption is preserved

17
Q

How does reduction of Uric acid normalize blood pressure?

A

Uric acid has an adverse effect on nitric oxide synthase in the macula densa of the kidney

18
Q

This drug may increase fasting glucose levels in patients with metabolic syndrome

A

Nicotinic acid

19
Q

Effect of nicotinic acid on fasting triglycerides

A

20-35% lowering

20
Q

The only currently available dude with predictable HDL cholesterol raising properties

A

Nicotinic acid

21
Q

Drug of choice to lower fasting triglyceride levels

A

Fibrates

gem fibrosis or fenofibrate

22
Q

% reduction of Tg by fibrates

23
Q

When is bariatric surgery an option for patients with metabolic syndrome?

A

BMI >= 40

Or >35 with comorbidities

24
Q

Precursor of Votamin D from the skin

A

7- dehydrocholesterol

25
The major circulating and storage form of Vitamin D
25 hydroxyvitamin D
26
Half life of Vit D
2-3 weeks
27
Actions of PTH with regards to calcium
Bone- ça release Kidney- ça reabsorption in distal tubules Proximal renal tubules- synthesis of 1,25 di hydroxyvitamin D, a hormone that increases GI calcium absorption
28
MC cause hyperparathyroidism
Autonomously functioning ADENOMAS or hyperplasia
29
PTH receptors are found in.. Osteoblasts Or osteoclasts
Osteoblasts! | Their osteoclastic action is cytosine mediated by osteoblasts
30
Action of calcitonin
Hypocalcemia peptide hormone indirect antagonist to actions of PTH Inhibits osteoclastic mediated bone resorption Stimulation of renal calcium clearance
31
Men syndrome lacking hyperparathyroidism
Men 2b
32
MC location parathyroid ADENOMAS
Inferior parathyroid glands
33
Mutations in protein encoding MENIN on chromosome 11q13
Men1
34
Inactivating mutation in single allele of CSR leading to inappropriately. Kemal or inc secretion of PTH
Familial benign hypercalcemia
35
Screening menopause
FSH
36
Screening hyperparathyroidism
Serum calcium Request for serum PTH if serum Ca is elevated
37
Screening PCOS
Free testosterone | DHEAs